Mozarc Medical

History

2023: Building a Company

On April 1, 2023, Medtronic and DaVita announced the formation of Mozarc Medical, which will specialize in the development of advanced kidney treatment technologies.

In May 2022, Medtronic and DaVita announced their intention to create a new structure for the production of medical equipment for kidney therapy. Under the terms of the agreement, the partners received equal shares in the established enterprise. Ven Manda, a 28-year veteran of Medtronic, has been appointed CEO of Mozarc Medical. The new company includes the Medtronic Renal Care Solutions (RCS) business. At the same time, the former RCS leadership group moved to the Mozarc Medical management team.

Mozarc Medical to improve quality of life for people with kidney disease with new approach to home dialysis

Mozarc Medical will focus on meaningful and innovative technologies to maintain kidney health that will improve patient care and increase access to care worldwide. While demands are changing and kidney care at home is becoming increasingly in demand, Mozarc Medical has a unique opportunity to offer patients state-of-the-art services, "Manda said.

Mozarc Medical will improve the quality of life of people with kidney disease through a new approach to home dialysis, it says. The solution will provide ease of use and clinical effectiveness. The investment in the new enterprise is based on a long-term desire to improve the means of therapy. The established company "is well positioned for long-term success." Medtronic added that the RCS business for the first three quarters of fiscal 2023 generated revenue of $64 million, $63 million and $70 million, respectively. Further business development and strengthening of market positions will provide strategic investments from Medtronic and DaVita.^[1]

Notes